Dialysis Clinic, Inc. Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Nashville TN United States (1971)

Organization Overview

First Clinical Trial
2005
NCT00293202
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dialysis Clinic, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 3)

Anemia, Iron-Deficiency (Phase 4)

Arteriovenous Fistula (Phase 2)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Fistula (Phase 2)

Hypertension (Phase 4)

Kidney Failure, Chronic (Phase 4)

Proteinuria (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 14